Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ALMS, CGON, IRON, HIMS, Eikon Therapeutics, and represent 92.64% of Foresite Capital Management V's stock portfolio.
  • Added to shares of these 6 stocks: Eikon Therapeutics (+$14M), HIMS (+$9.7M), PHVS (+$5.5M), IRON, NRIX, ALMS.
  • Started 3 new stock positions in Eikon Therapeutics, PHVS, NRIX.
  • Reduced shares in these 2 stocks: NTRA (-$15M), MAZE.
  • Sold out of its position in NTRA.
  • Foresite Capital Management V was a net buyer of stock by $23M.
  • Foresite Capital Management V has $271M in assets under management (AUM), dropping by 64.84%.
  • Central Index Key (CIK): 0001792206

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Foresite Capital Management V holds 9 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alumis (ALMS) 47.9 $130M +2% 5.9M 22.03
 View chart
Cg Oncology (CGON) 25.1 $68M 1.0M 67.68
 View chart
Disc Medicine (IRON) 8.8 $24M +25% 374k 63.94
 View chart
Hims & Hers Health Com Cl A (HIMS) 5.7 $15M +170% 738k 20.76
 View chart
Eikon Therapeutics 5.1 $14M NEW 1.3M 10.58
 View chart
Lyell Immunopharma (LYEL) 3.5 $9.6M 477k 20.06
 View chart
Pharvaris N V (PHVS) 2.0 $5.5M NEW 194k 28.25
 View chart
Nurix Therapeutics (NRIX) 1.5 $4.1M NEW 265k 15.50
 View chart
Maze Therapeatics (MAZE) 0.3 $773k -69% 26k 29.85
 View chart

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020

View all past filings